Entries from blog.bioethics.net tagged with 'FDA'

Bioethicist Charo Accepts Key FDA Post

University of Wisconsin law professor R. Alta Charo has accepted the post of senior adviser in the Office of the Commissioner of the FDA. According to the Chicago Trib, as of August 30th, Charo will be part of an elite group of policy advisors asked the tough questions on food... (read the rest)

It's Not August! But The August Issue of AJOB is Already Online at Bioethics.net

Now available at bioethics.net is the August issue of The American Journal of Bioethics. This month's issue contains articles ranging in topics from organ conscription and whether the US ought to have an opt-out system for organ donation and a number of thought experiments supporting that position by Delaney and... (read the rest)

Pucker Up!

Ladies, how much risk of lead exposure would you be willing to undergo for ruby red lips? Is it even something to be concerned about? Well, it depends on who you ask. According to the NYT, a debate is ensuing at the FDA over lead suspected in tubes of women's... (read the rest)

Will Your Tweets Keep You Healthy Or Make You Sick?

Google has been tracking flu trends to monitor disease outbreaks for some time, but with the most recent outbreak of swine flu, social media has taken on a new role in the monitoring of health in our lives. Not only did we, here at bioethics.net, decide to create pandemic.bioethics.net on... (read the rest)

Dr. Hamburg, Divest Thyself

One of the wealthiest of the Obama administration appointees, Dr. Margaret Hamburg, has to offload her stock pretty quickly--apparently that's what comes from being married to a very successful hedge fund manager and holding a wide range of health and other medical related stock, says the Wall Street Journal. The... (read the rest)

President Obama Takes Food Ethics Seriously

In his Saturday morning radio address, President Obama took on the issue of food safety as a moral responsibility for our nation. The lack of food safety and a "demoralized" Food and Drug Administration was characterized as a "threat to public health" by the President, according to the Wall Street... (read the rest)

DBS for OCD? OMG!

As I read on the Triage health blog at the Chicago Tribune, deep brain stimulation (DBS) has been approved by the FDA as a treatment for obsessive-compulsive disorder (OCD). Medtronic was given "humanitarian device exemption" for its DBS device based on the data: 26 patients were shown to have a... (read the rest)

Goats: Not Just for Making Feta Cheese and For Petting Zoos Anymore

Researchers have finally done it. Engineered a goat to save lives. On Friday, the FDA approved a genetically engineered goat that is able to produce in its milk (not for feta cheese making, mind you) a drug that will save the lives of patients born with a rare hereditary deficiency... (read the rest)

A Well-Timed Step Forward

Today, the FDA announced its approval of the first stem cell clinical trial in human beings. Geron will perform the trial on 10 spinal cord injured patients. To call this trial, "medical treatment" is the biggest overstatement one could make--and fully illustrates one of the biggest ethical problems with stem... (read the rest)

Move Over CoverGirl and Revlon. Here Comes Latisse.

Here is one enhancement I think the world could have lived without. From the makers of Botox, Allergan, Inc, comes a drug that will make your lashes--longer, thicker, darker, Latisse. According to the Washington Post, the FDA has approved this drug for daily use on the upper (but only the... (read the rest)

When It Comes to Nano, Feds are Passing the Buckyball

According to an article from Scientific American, the National Research Council has weighed in on the regulatory efforts of the federal agencies responsible for monitoring the safety and use of nanoparticles and objects using nanotechnologies. For the more than 800 consumer products using nanotechnology, the NRC has said that no... (read the rest)

Medical Ads on YouTube Go Unregulated

According to the Wall Street Journal Health Blog, a consumer advocacy group is up in arms over unregulated pharma ads found on YouTube. The Prescription Project reports that medical device ads for prominent companies appear on YouTube, but without the disclaimers and warnings that pharmaceutical or medical device ads must... (read the rest)

deCODE demoted

I have something to tell you about deCODE--there's good news and there's bad news. First, for the good news: today deCODE announced that it has filed an IND with the FDA for a new drug on cognition designed to combat memory loss and the other effects of Alzheimer's disease. The... (read the rest)

Beware! Food Allergens WIthin!

The Washington Post reported on Tuesday that the FDA is considering changing food labeling for products that may contain allergens such as nuts, wheat, and others. Advocates say that there are just too many ways to say that your favorite candy bar was made in a factory containing nuts or... (read the rest)

Coming Soon: Robo-Pancreas

Thanks to the folks at Engaget we have learned that researchers have developed an artificial pancreas complete with a remote device that monitors your blood sugar, morning, noon and night. This device could be a lifesaver for those with diabetes, particularly juvenile diabetes, if it could be a permanent implant... (read the rest)

Zetia situation demonstrates need for a more open clinical trial process

By Alan C. Milstein The news about Zetia and Vytorin once again raises a major problem in the way the FDA allows drug companies to control the information about the clinical trials they conduct, often to the detriment to public health. Apparently, Merck and Schering-Plough had completed the trial which... (read the rest)

Art Caplan at MSNBC: Report paints grim picture of drug trial safety

Art writes that criticism of the FDA's weak oversight is on target, but Congress shares the blame: When a bridge collapses in an American city or a mine implodes, it does not take long before government gets in motion to figure out what to do about the problem. We see... (read the rest)

Regulating nanotechnology

The FDA's Nanotechnology Task Force recently released a report laying out its take on regulation of products containing nanoscale materials. Here's a clip: A general finding of the report is that nanoscale materials present regulatory challenges similar to those posed by products using other emerging technologies. However, these challenges may... (read the rest)

feed these results

If you use an RSS reader, you can subscribe to a feed of all future entries from blog.bioethics.net tagged 'FDA'. [What is this?]

Subscribe to feed Subscribe to feed

tags from blog.bioethics.net

abortion (9)

Abraham Lincoln (1)

academia (8)

academic publishing (6)

addiction (3)

Africa (2)

aging (2)

agriculture (1)

airlines (1)

AJOB (22)

AJOB Neuroscience (1)

AJOB Primary Research (1)

alcohol (1)

allergies (1)

ALS (1)

Alta Charo (1)

AMA (2)

American Journal of Bioethics (6)

Andrew Wakefield (1)

animals (16)

anorexia (1)

anthrax (1)

APA (1)

archaeology (1)

Art Caplan (26)

artificial intelligence (2)

ASBH (3)

assisted reproduction (1)

athletics (1)

autism (9)

award (1)

Barack Obama (1)

basic research (1)

beyond genetics (1)

bias (1)

BIID (1)

BioEdge (1)

bioethics (32)

bioethics.net (17)

biotechnology (6)

bioterrorism (1)

birth weight (1)

blog.bioethics.net (10)

blogs (3)

BMJ (2)

book (1)

brain-computer interface (1)

breast cancer (4)

Britain (1)

business ethics (1)

cadavers (1)

California (2)

Canada (1)

cancer (3)

caregiver (1)

Catholic chuch (3)

CDC (2)

Centers for Disease Control and Prevention (1)

cessation (1)

cheating (1)

chemistry (1)

chemotherapy (2)

children (31)

chimeras (5)

China (6)

chocolate (1)

Christian (1)

cigarettes (1)

civil rights (1)

clinical ethics (5)

clinical trials (8)

cloning (18)

Coast IRB (1)

COBRA (1)

commission (2)

conferences (1)

conflict of interest (6)

consumer (1)

contraception (1)

cord blood (1)

cosmetic surgery (4)

cosmetics (1)

courts (1)

CPR (1)

Craig Venter (8)

crime (1)

databases (3)

death (4)

death penalty (5)

dementia (1)

democracy (1)

Democrats (1)

dental health (1)

developing countries (7)

development (1)

devices (1)

diabetes (1)

disability (1)

diversity (1)

DNA (4)

DNR (2)

doctors (41)

donation (1)

drug abuse (2)

e-card (1)

eating disorders (1)

economics (3)

education (1)

egg donation (5)

eggs for research (1)

elderly (1)

election 2008 (15)

electronic health records (1)

Elsevier (4)

embryos (13)

emergencies (2)

emergency research (1)

empirical bioethics (2)

employment (1)

end of life (4)

enhancement (25)

environment (3)

epidemics (1)

epidemiology (2)

ethical (1)

ethicist (2)

ethics (28)

Europe (1)

euthanasia (3)

evolution (3)

exercise (1)

Ezekiel Emanuel (1)

face (1)

facebook (4)

families (3)

FDA (18)

federalism (2)

fertility tourism (1)

flight simulators (1)

fMRI (2)

following up (1)

food (17)

food ethics (6)

forensics (1)

funding (2)

games (1)

gay rights (1)

gender (4)

gender theory (1)

gene therapy (3)

genetic disease (9)

genetic engineering (1)

genetic modification (5)

genetic testing (26)

genetics (24)

genomics (12)

Geron (1)

glenn mcgee (2)

Glenn McGee (15)

Google (1)

government (5)

Harvard (2)

healing (1)

health (16)

health 2.0 (1)

health insurance (27)

health reform (18)

healthcare (40)

hearing (1)

heart attack (2)

HIV/AIDS (3)

holocaust (1)

hospitals (8)

human rights (1)

humanities (1)

humans (1)

Hurricane Katrina (1)

Hwang Woo-suk (2)

Ian Wilmut (1)

illness (1)

industry (7)

infants (1)

infectious disease (12)

influenza (18)

informed consent (3)

injury (1)

Institute of Medicine (1)

insurance (2)

international (7)

internet (8)

interview (1)

iphone (2)

iPS cells (19)

Iran (1)

IRB (2)

IVF (2)

James Fossett (1)

John McCain (1)

Johns Hopkins (2)

Johns Hopkins University (1)

Joseph Biden (3)

journalism (2)

Kevorkian (2)

kidneys (2)

law (15)

legislation (2)

Leon Kass (1)

liberty (1)

license (1)

living donors (1)

longevity (2)

lying (1)

March of Dimes (1)

Marfan syndrome (1)

marriage (1)

massage (1)

masters degree (1)

media (13)

medical devices (5)

medical education (3)

medical ethics (10)

medical marijuana (2)

medical schools (11)

Medicare (2)

medicine (5)

memory (1)

mental illness (2)

MercatorNet (1)

Merck (4)

military (1)

Mitt Romney (1)

mobile (1)

models (2)

money (3)

Montana (1)

morality (3)

multiple births (1)

nanotechnology (18)

neuroethics (20)

neuroimaging (2)

neuromarketing (2)

neuroscience (27)

New York (1)

news (1)

news top 5 (17)

NHS (1)

NIH (2)

northfield laboratories (1)

Notre Dame (1)

NUBC (1)

nurse (1)

nutraceuticals (1)

nutrition (1)

NYT (2)

NYU (1)

Obama (5)

obesity (12)

octomom (1)

octuplets (3)

Olympics (2)

online (1)

oprah (1)

organ donation (19)

organ sales (5)

organ transplants (18)

pain managment (2)

pandemics (8)

parents (1)

partner notification (1)

patient rights (4)

patients (7)

Paul Wolpe (1)

payment (1)

peer-review (1)

Perfect Baby (1)

personalized medicine (4)

Peter Singer (1)

PGD (1)

pharmaceuticals (24)

pharmacists (5)

philanthropy (1)

philosophy (5)

physician assisted suicide (3)

placebo (1)

planned parenthood (1)

podcasts (1)

policy (7)

politics (69)

polyheme (1)

popularized science (11)

pregnancy (5)

premiums (1)

President Obama (2)

prison (1)

privacy (12)

pro-life (1)

provigil (1)

psychology (8)

public health (30)

public opinion (3)

quality improvement (1)

radiology (1)

ranking (1)

rationing (2)

records (1)

reform (1)

regulation (13)

religion (7)

Reloxin (1)

reproduction (22)

reproductive technology (21)

research (31)

research ethics (26)

research funding (3)

residency (2)

review board (1)

Rick Weiss (1)

robots (10)

rss (1)

Sarah Palin (1)

SCHIP (1)

scholarship (4)

school (1)

science (2)

sex (4)

sex education (2)

sleep (2)

smoking (4)

Snuppy (1)

social networking (1)

South Korea (3)

space (1)

sperm donation (6)

sports (7)

Stanford University (1)

state regulation (18)

STD (1)

stem (1)

stem cell research (8)

stem cells (71)

stroke (1)

surgeon general (1)

surgery (2)

swine (13)

synthetic biology (10)

taxes (3)

technology (9)

teenagers (1)

telemedicine (1)

television (7)

terminal illness (1)

terrorism (1)

Texas (4)

The Scientist (4)

therapy (2)

tobacco (1)

Today Show (3)

torture (1)

transgenic (1)

transplantation (3)

Twitter (1)

UK (2)

UMBC (1)

undergraduate (1)

uninsured (1)

University of Pennsylvania (1)

vaccines (17)

vatican (1)

veterans affairs (1)

veterans day (1)

video (1)

voting (1)

war (1)

war on terror (1)

Washington Post (1)

weather (1)

Wesley Smith (1)

WHO (1)

women (10)

work (1)

xenograft (1)

yuck factor (3)

Zoloth (1)